OBJECTIVE: To create a heightened awareness of the proposals for nonprescription product labeling changes being explored by the Food and Drug Administration and the Nonprescription Drug Manufacturers Association, and to review selected new self-care products that are now available in the United States. DATA SOURCES: Recent clinical and pharmaceutical industry literature. DATA SYNTHESIS: The debate continues about what constitutes sufficient labeling information for a nonprescription drug product. However, one fact remains. Numerous nonprescription drug products, including home diagnostic products and accessories, will continue to become available on the U.S. market. It is important that the pharmacist become as knowledgeable as possible about these products, and be capable of educating consumers on their appropriate use. CONCLUSION: New products cited in this review article are valuable new additions to the self-care product pool that provides an increasing array of products for consumer use.

Asthma↗

PubMedDate not supplied

New OTC drugs and devices 1998: a selective review.

OBJECTIVE: To create a heightened awareness of the marketing strategy of dual labeling, i.e., labeling of two benefits on a nonprescription drug product, and to review a selection of new self-care products that became available in 1998 for consumer use in the United States. DATA SOURCES: Recent clinical and pharmaceutical industry literature. DATA SYNTHESIS: It is critical for the pharmacist to be aware of the use of dual labeling and to be able to appropriately counsel and direct patients on how to read and understand dual labeling. In addition, numerous nonprescription products, including home diagnostic products and accessories, will continue to become available on the U.S. market. It is important that the pharmacist become as knowledgeable as possible about these, and be well positioned to educate patients about their appropriate use. CONCLUSION: The new products cited in this review represent valuable new additions to the self-care product pool.

Drug Labeling↗

PubMedDate not supplied

New OTC drugs and devices 1999: a selective review.

OBJECTIVES: To educate pharmacists about newly introduced nonprescription products/devices/diagnostic products, and to create a heightened awareness of the dilemma of dietary supplements and the problems their use poses for consumers and pharmacists. DATA SOURCES: Recent clinical and pharmaceutical industry literature. DATA SYNTHESIS: It is critical for the pharmacist to be knowledgeable about dietary supplements to be able to appropriately counsel patients on benefits and risks associated with their use. In addition, numerous other nonprescription products, including home diagnostic products and accessories, will continue to become available on the U.S. market. It is important that the pharmacist become as knowledgeable as possible about these and be capable of educating the consuming public about their appropriate use. CONCLUSION: Dietary supplements will continue to flood the self-care market. Pharmacists need a balanced understanding of these products to assist the consumer. The new nonprescription medications cited in this review represent valuable additions to the growing array of self-care products for consumer use.

Dietary Supplements↗

PubMedDate not supplied

New OTC drugs and devices 2000: a selective review.

OBJECTIVES: To create a heightened awareness of the issues confronting pharmacists in the self-care arena. To educate pharmacists about newly introduced nonprescription products, devices, and diagnostic products. DATA SOURCES: Recently published governmental, clinical, and pharmaceutical industry literature. DATA SYNTHESIS: Several developments during the previous year have important implications for patient self-care. The Food and Drug Administration recommended the withdrawal of phenylpropanolamine from the market and denied proposals to switch lovastatin, pravastatin, and omeprazole to nonprescription status. Widespread use of dietary supplements in the face of insufficient data on their safety and efficacy continued to be a problem in 2000, although there were several encouraging developments. In 2000, new over-the-counter products were introduced for, among other purposes, treating acid-peptic disorders, musculoskeletal injuries, dermatologic disorders, and minor wounds. Numerous nonprescription products, including sophisticated home diagnostic products and accessories, continue to become available on the U.S. market. It is important that the pharmacist become as knowledgeable as possible about these products so he or she can educate patients about their appropriate use. CONCLUSION: Patients will continue to place an increasing emphasis on self-care. To assist them, pharmacists must remain up to date on trends and have a balanced understanding of new products. The new nonprescription medications and diagnostic products discussed in this review article represent valuable additions to the growing array of self-care products.

Equipment and Supplies↗

PubMedDate not supplied

New OTC drugs and devices: a selective review.

Explore the source record for details and available documents.

Humans↗